These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33894137)

  • 1. COVID-19 vaccine prioritisation for people with disabilities.
    Epstein S; Ayers K; Swenor BK
    Lancet Public Health; 2021 Jun; 6(6):e361. PubMed ID: 33894137
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 vaccine prioritisation for type 1 and type 2 diabetes.
    Powers AC; Aronoff DM; Eckel RH
    Lancet Diabetes Endocrinol; 2021 Mar; 9(3):140-141. PubMed ID: 33476583
    [No Abstract]   [Full Text] [Related]  

  • 3. Disparities in COVID-19 Vaccination Status, Intent, and Perceived Access for Noninstitutionalized Adults, by Disability Status - National Immunization Survey Adult COVID Module, United States, May 30-June 26, 2021.
    Ryerson AB; Rice CE; Hung MC; Patel SA; Weeks JD; Kriss JL; Peacock G; Lu PJ; Asif AF; Jackson HL; Singleton JA
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(39):1365-1371. PubMed ID: 34591826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rethinking the Current Older-people-first Policy for COVID-19 Vaccination in Japan.
    Matsui K; Inoue Y; Yamamoto K
    J Epidemiol; 2021 Sep; 31(9):518-519. PubMed ID: 34148916
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 vaccine prioritisation for people with cystic fibrosis.
    Carr SB; Cosgriff R; Harutyunyan S; Middleton PG; Ruseckaite R; Ahern S; Daneau G; Filho LVRFDS; Stephenson AL; Cheng SY; Melo J; Corvol H; Burgel PR; Nährlich L; McKone E; Colombo C; Salvatore M; Padoan R; Abdrakhmanov O; Gulmans V; Byrnes CA; Amelina E; Kondratyeva E; Zhekayte E; Kashirskaya N; Zampoli M; Pastor-Vivero MD; Mondejar-Lopez P; de Monestrol I; Jung A; McClenaghan E; Brownlee K; Rizvi S; Goss CH; Elbert A; Faro A; Gutierrez H; Marshall BC
    J Cyst Fibros; 2021 Jul; 20(4):715-716. PubMed ID: 33941502
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA authorizes Pfizer-BioNTech COVID-19 vaccine.
    Med Lett Drugs Ther; 2021 Jan; 63(1615):1-2. PubMed ID: 33646996
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA authorizes Moderna COVID-19 vaccine.
    Med Lett Drugs Ther; 2021 Jan; 63(1616):9-10. PubMed ID: 33512345
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021.
    CDC COVID-19 Vaccine Breakthrough Case Investigations Team
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(21):792-793. PubMed ID: 34043615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine Literacy-helping Everyone Decide to Accept Vaccination.
    Ratzan SC; Parker RM
    J Health Commun; 2020 Oct; 25(10):750-752. PubMed ID: 33719880
    [No Abstract]   [Full Text] [Related]  

  • 10. The next steps for US vaccine mandates.
    Jaffe S
    Lancet; 2022 Jan; 399(10323):425-426. PubMed ID: 35093218
    [No Abstract]   [Full Text] [Related]  

  • 11. Source of information on COVID-19 vaccine and vaccine hesitancy among U.S. Medicare beneficiaries.
    Kim J; Kim Y; Li Y
    J Am Geriatr Soc; 2022 Mar; 70(3):677-680. PubMed ID: 34894409
    [No Abstract]   [Full Text] [Related]  

  • 12. Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply.
    Tuite AR; Zhu L; Fisman DN; Salomon JA
    Ann Intern Med; 2021 Apr; 174(4):570-572. PubMed ID: 33395334
    [No Abstract]   [Full Text] [Related]  

  • 13. [Defining priorities, the case of of COVID-19 vaccine].
    Frigerio M
    G Ital Cardiol (Rome); 2021 Jun; 22(6):509-510. PubMed ID: 34037597
    [No Abstract]   [Full Text] [Related]  

  • 14. Ensuring Equitable COVID-19 Vaccination for People With Disabilities and Their Caregivers.
    Wiggins LD; Jett H; Meunier J
    Public Health Rep; 2022; 137(2):185-189. PubMed ID: 34969301
    [No Abstract]   [Full Text] [Related]  

  • 15. Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment.
    Paltiel AD; Zheng A; Schwartz JL
    Ann Intern Med; 2021 Apr; 174(4):568-570. PubMed ID: 33395345
    [No Abstract]   [Full Text] [Related]  

  • 16. The ethics of COVID-19 vaccine distribution.
    Nichol AA; Mermin-Bunnell KM
    J Public Health Policy; 2021 Sep; 42(3):514-517. PubMed ID: 34012014
    [No Abstract]   [Full Text] [Related]  

  • 17. Wednesday, January 20, 2021.
    Hotez PJ
    Microbes Infect; 2021; 23(1):104775. PubMed ID: 33220444
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination.
    Kadire SR; Wachter RM; Lurie N
    N Engl J Med; 2021 Mar; 384(9):e28. PubMed ID: 33596347
    [No Abstract]   [Full Text] [Related]  

  • 19. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021.
    Oliver SE; Gargano JW; Scobie H; Wallace M; Hadler SC; Leung J; Blain AE; McClung N; Campos-Outcalt D; Morgan RL; Mbaeyi S; MacNeil J; Romero JR; Talbot HK; Lee GM; Bell BP; Dooling K
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(9):329-332. PubMed ID: 33661860
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.